1.The Effects of Gonadotropins on the Development of Ovarian Cancer.
Hye Rhee YOO ; Myung Keun YOON ; Young Han PARK ; Hye Rim PARK ; Pong Rheem JANG
Korean Journal of Obstetrics and Gynecology 2004;47(9):1698-1705
OBJECTIVE: We performed immunohistochemistry for the evaluation of follicle stimulating hormone receptor (FSHR), luteinizing hormone receptor (LHR) expression in the ovarian tumors and examined the blood level of the gonadotropins in ovarian cancer patients to investigate ovarian carcinogenesis process related to gonadotropins. METHODS: Between January 2002 and July 2003, 25 patients with ovarian tumors were treated in the Hallym University Sacred Heart Hospital. 25 ovarian tumors including 7 borderline tumors, 1 sex cord stromal tumor, 1 germ cell tumor, and 16 carcinomas were examined for FSHR, LHR expression by immunohistochemistry. Serum gonadotropins were collected from 13 cases of 25 ovarian tumors who were not taking hormones at the time of blood collection. RESULTS: Followings are results summarized. 1. Mean FSH levels were lower among cases compared with controls. LH levels were lower among cases than controls, but the difference was not statistically significant. 2. The steady decline of FSHR, LHR expression from borderline tumor (86%, 100%) to carcinoma (56%, 43%) is observed. 3. Patients showing significant gonadotropins receptors expression showed lower serum FSH and LH levels when compared with patients with no detectable gonadotropins receptors. CONCLUSION: The presence of FSHR, LHR in ovarian tumors provide additional evidence supporting the relation of gonadotropins and ovarian carcinogenesis. But, this study did not support the hypothesis that pituitary goandotropins increase the risk of ovarian cancer. The decline of receptor expression from borderline tumors to carcinoma suggests that FSH, LH may be needed in early ovarian cancer development. If further studies of gonadal peptides and gonadotropins are done, we can suggest the cut-off value of gonadotropins on ovarian carcinogenesis.
Carcinogenesis
;
Gonadotropins*
;
Gonads
;
Heart
;
Humans
;
Immunohistochemistry
;
Neoplasms, Germ Cell and Embryonal
;
Ovarian Neoplasms*
;
Peptides
;
Receptors, FSH
;
Receptors, Gonadotropin
;
Receptors, LH
;
Sex Cord-Gonadal Stromal Tumors
2.Giant Follicular Ovarian Cyst with Torsion in Juvenile Primary Hypothyroidism.
Jung Won LEE ; Hyun Jin KIM ; Hae Soon KIM
Journal of Korean Society of Pediatric Endocrinology 2003;8(1):87-90
Multicystic ovary was first described by Silver in 1958 as a rare case feature of acquired primary hypothyroidism. In 1980, Lindsay reported four girls with hypothyroidism associated with multicystic ovary diagnosed by pelvic ultrasonography. The mechanism of ovarian cyst formation and pseudoprecocious puberty in severe hypothyroidism in childhood are unknown. Increased ovarian sensitivity to GnRH and increased TSH level which acts on FSH receptor is one of the mechanism explained. We report a case of a girl with primary hypothyroidism presented with pseudoprecocious puberty and giant follicular ovarian cyst with torsion.
Adolescent
;
Female
;
Gonadotropin-Releasing Hormone
;
Humans
;
Hypothyroidism*
;
Ovarian Cysts*
;
Ovary
;
Puberty
;
Receptors, FSH
;
Silver
;
Ultrasonography
3.High levels of testosterone inhibit ovarian follicle development by repressing the FSH signaling pathway.
Tao LIU ; Yu-qian CUI ; Han ZHAO ; Hong-bin LIU ; Shi-dou ZHAO ; Yuan GAO ; Xiao-li MU ; Fei GAO ; Zi-jiang CHEN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2015;35(5):723-729
The effect of high concentrations of testosterone on ovarian follicle development was investigated. Primary follicles and granulosa cells were cultured in vitro in media supplemented with a testosterone concentration gradient. The combined effects of testosterone and follicle-stimulating hormone (FSH) on follicular growth and granulosa cell gonadotropin receptor mRNA expression were also investigated. Follicle growth in the presence of high testosterone concentrations was promoted at early stages (days 1-7), but inhibited at later stage (days 7-14) of in vitro culture. Interestingly, testosterone-induced follicle development arrest was rescued by treatment with high concentrations of FSH (400 mIU/mL). In addition, in cultured granulosa cells, high testosterone concentrations induced cell proliferation, and increased the mRNA expression level of FSH receptor (FSHR), and luteinized hormone/choriogonadotropin receptor. It was concluded that high concentrations of testosterone inhibited follicle development, most likely through regulation of the FSH signaling pathway, although independently from FSHR downregulation. These findings are an important step in further understanding the pathogenesis of polycystic ovary syndrome.
Androgens
;
pharmacology
;
Animals
;
Cell Proliferation
;
drug effects
;
Female
;
Follicle Stimulating Hormone
;
genetics
;
metabolism
;
pharmacology
;
Gene Expression Regulation, Developmental
;
Granulosa Cells
;
cytology
;
drug effects
;
metabolism
;
Mice
;
Ovarian Follicle
;
cytology
;
drug effects
;
growth & development
;
metabolism
;
Primary Cell Culture
;
RNA, Messenger
;
genetics
;
metabolism
;
Receptors, FSH
;
genetics
;
metabolism
;
Receptors, Gonadotropin
;
genetics
;
metabolism
;
Receptors, LH
;
genetics
;
metabolism
;
Signal Transduction
;
drug effects
;
genetics
;
Testosterone
;
antagonists & inhibitors
;
pharmacology
4.Increased Serum Level of Inhibin in Oligo-amenorrheic Women with Polycystic Ovaries.
Jae Sook ROH ; Jung Bae YOO ; Hyung MOON ; Yoon Yeong HWANG
Korean Journal of Fertility and Sterility 1998;25(1):93-102
Normal and abnormal follicular growth and steroidogenesis depend on gonadotropins as well as intraovarian peptides, which may mediate or potentiate gonadotropin action. Inhibin also affect follicular development and steroidogenesis and may play a role in dominant follicle selection and follicular atresia. Therefore, we studied the differences of serum inhibin, gonadotropin and androgen levels in the women with only the ultrasound findings and no disorder, and polycystic ovary (PCO) with ovulatory disturbance. We prospectively analysed forty-three women with PCO. The diagnosis of PCO was based on typical appearance of the ovaries on TVS. Twelve women with regular menstrual cycle and normal ovarian morphology were selected as control. Basal levels of inhibin, luteinizing hormone(LH), follicle stimulating hormone(FSH), estradiol(E2), testosterone(T), androstenedione(ADD), dehydroepiandrosterone-sulfate(DS), prolactin and TSH in serum were determined. There were significant differences in basal LH levels and LH/FSH ratio between the control and the women with PCO. The basal levels of inhibin and E2 in the oligo-amenorrheic PCO (N=34) were significantly higher than those in the control. There was higher negative correlation between the inhibin and T levels in the oligo-amenorrheic PCO, but, not in the regular cycling PCO. Also, there was higher positive correlation between the LH and T levels in the oligo-amenorrheic PCO, but not in the regular cycling PCO. These data presume that the initial event of PCO is elevated pituitary LH secretion. Elevated levels of LH may down-regulate LH receptors on granulosa cells and also cause hypertrophy of the thecal layer. High level of androgen secreted by the hypertrophied thermal layer may stimulate inhibin secretion from granulosa cells and can be converted to estrogen by extraovarian tissues and could serve to augment pituitary sensitivity to GnRH with a resultant secretion of more LH follicular development and dominant follicle selection resulted in ovulatory disturbance.
Diagnosis
;
Estrogens
;
Female
;
Follicular Atresia
;
Gonadotropin-Releasing Hormone
;
Gonadotropins
;
Granulosa Cells
;
Humans
;
Hypertrophy
;
Inhibins*
;
Lutein
;
Menstrual Cycle
;
Ovary*
;
Peptides
;
Prolactin
;
Prospective Studies
;
Receptors, LH
;
Ultrasonography
5.Molecular Mechanism of GnRH Interaction with GnRH Receptor in an Evolutionary Viewpoint.
Jae Young SEONG ; Hyuk Bang KWON
Journal of Korean Society of Endocrinology 2000;15(6):779-790
No Abstract Available.
Gonadotropin-Releasing Hormone*
;
Receptors, LHRH*
6.Fluoride Exposure, Follicle Stimulating Hormone Receptor Gene Polymorphism and Hypothalamus-pituitary-ovarian Axis Hormones in Chinese Women.
Ming Xu ZHAO ; Guo Yu ZHOU ; Jing Yuan ZHU ; Biao GONG ; Jia Xiang HOU ; Tong ZHOU ; Li Ju DUAN ; Zhong DING ; Liu Xin CUI ; Yue BA
Biomedical and Environmental Sciences 2015;28(9):696-700
The effects of fluoride exposure on the functions of reproductive and endocrine systems have attracted widespread attention in academic circle nowadays. However, it is unclear whether the gene-environment interaction may modify the secretion and activity of hypothalamus-pituitary- ovarian (HPO) axis hormones. Thus, the aim of this study was to explore the influence of fluoride exposure and follicle stimulating hormone receptor (FSHR) gene polymorphism on reproductive hormones in Chinese women. A cross sectional study was conducted in seven villages of Henan Province, China during 2010-2011. A total of 679 women aged 18-48 years were recruited through cluster sampling and divided into three groups, i.e. endemic fluorosis group (EFG), defluoridation project group (DFPG), and control group (CG) based on the local fluoride concentration in drinking water. The serum levels of gonadotropin releasing hormone (GnRH), follicle stimulating hormone (FSH), luteinizing hormone (LH), and estradiol (E2) were determined respectively and the FSHR polymorphism was detected by real time PCR assay. The results provided the preliminary evidence indicating the gene-environment interaction on HPO axis hormones in women.
Adolescent
;
Adult
;
Age Factors
;
Asian Continental Ancestry Group
;
China
;
Cross-Sectional Studies
;
Estradiol
;
blood
;
Female
;
Fluoridation
;
adverse effects
;
Fluorides
;
administration & dosage
;
adverse effects
;
urine
;
Follicle Stimulating Hormone
;
blood
;
Gene-Environment Interaction
;
Gonadotropin-Releasing Hormone
;
blood
;
Humans
;
Hypothalamus
;
physiology
;
Luteinizing Hormone
;
blood
;
Middle Aged
;
Ovary
;
physiology
;
Pituitary Gland
;
physiology
;
Polymorphism, Single Nucleotide
;
Receptors, FSH
;
genetics
;
Tobacco Smoke Pollution
;
Young Adult
7.The change of estrogen and progesterone receptors in uterine myoma after treatment with GnRH analogue.
Ki Hyun PARK ; Won Il PARK ; Bo Yeon LEE ; Byung Suk LEE ; Dong Jae CHO ; Dong Hoon HWANG ; Chan Ho SONG
Korean Journal of Obstetrics and Gynecology 1993;36(7):1913-1918
No abstract available.
Estrogens*
;
Gonadotropin-Releasing Hormone*
;
Leiomyoma*
;
Progesterone*
;
Receptors, Progesterone*
8.Effects of Toluene, Xylene and Trichloroethylene on the Regulation of GnRH, GnRH Receptor and Pit-1 Gene Expression in Male Rat Hypothalamus and Pituitary.
Dae Hwan KIM ; Hun LEE ; Chae Kwan LEE ; Dae Sung KANG ; Jung Ho KIM ; Jong Tae LEE ; Jin Ho CHUN ; Chae Un LEE ; No Suk KI
Korean Journal of Occupational and Environmental Medicine 1998;10(2):267-281
The workplace exposure of chemicals has steadily increased, therefore the concern for subsequent effect on reproductive outcome has been an important issue in occupational medicine. In previous studies, higher rates of spontaneous abortion, reduced fertility and menstrual disorder among women, and an impairment of sperm quantity and quality among men have been associated with a wide variety of chemical agents. This study was conducted to evaluate the effects of toluene, xylene and trichloroethylene (TCE) injection on the mRNA levels of GnRH, GnRH receptor and Pit-1 genes in male rats hypothalamus and pituitary and the effects on the plasma levels of FSH, LH, prolactin and testosterone. Sprague-Dawley male rats were divided into five groups of five each according to concentration of toluene, xylene and TCE. The rats were injected subcutaneously to 0, 50, 100, 200, 400 mg/kg body weight/day of toluene, xylene and TCE, respectively for 6 days. Rat brains were excised and hypothalamus and pituitary were separated. Reverse transcription-polymerase chain reaction (RT-PCR) and RNase protection assay (RPA) were used to evaluate the GnRH, GnRH receptor and Pit-1 mRNA levels. Plasma concentrations of FSH, LH, prolactin and testosterone were assayed by radioimulunoassay (RIA). The results were as follows; 1. GnRH, GnRH receptor and Pit-1 mRNA levels in toluene and xylene injected groups, and GnRH receptor mRNA levels in TCE injected group were lowered dose-dependently. Especially, GnRH receptor and Pit-1 mRNA levels in 200 mg/kg of toluene injected group, and GnRH, GnRH receptor and Pit-1 mRNA levels in 400 mg/kg of toluene injected group were significantly lowed than control group (p<0.05). GnRH receptor and Pit-1 mRNA levels in 400 mg/kg of xylene injected group, and GnRH receptor mRNA levels in 400 mg/kg of TCE injected group were significantly lower than control group (p<0.05). 2. The plasma levels of prolactin and testosterone in 400 mg/kg of toluene injected group, and LH in 100, 200 and 400 mg/kg of xylene injected group, and testosterone in 400 mg/kg of TCE injected group were significantly lower than control group (p<0.05). In conclusion, we speculated that toluene and xylene affected reproductive system secondarily through hypothalamus-pituitary axis, and TCE affected directly through steroidogenesis. And we recomended that further study for assessment of the reproductive toxiclty of mixed organic solvent exposures should be conducted.
Abortion, Spontaneous
;
Animals
;
Axis
;
Brain
;
Female
;
Fertility
;
Gene Expression*
;
Gonadotropin-Releasing Hormone*
;
Humans
;
Hypothalamus*
;
Male*
;
Occupational Medicine
;
Plasma
;
Pregnancy
;
Prolactin
;
Rats*
;
Rats, Sprague-Dawley
;
Receptors, LHRH*
;
Ribonucleases
;
RNA, Messenger
;
Spermatozoa
;
Testosterone
;
Toluene*
;
Trichloroethylene*
;
Xylenes*
9.Methylphenidate and Central Precocious Puberty: A Probable Side Effect among Seven Children with the Attention Deficit Hyperactivity Disorder
Ayça Törel ERGÜR ; Hesna GÜL ; Ahmet GÜL
Clinical Psychopharmacology and Neuroscience 2019;17(3):446-449
Methylphenidate (MPH) is the most preferred drug for treatment of the attention deficit hyperactivity disorder (ADHD). Here, we aimed to discuss the possible effects and mechanisms of MPH on precocious puberty (PP) via a case series with seven children who had normal body mass index. In this case series we evaluated seven children with ADHD, who had received MPH for at least 6 months (0.5 mg/kg/dose three times a day, maximum 60 mg) and admitted to Department of Pediatric Endocrinology with PP symptoms. The mean age was 8.16 years. Basal hormonal levels (luteinizing hormone [LH], follicle stimulating hormone, and estrogen/testosterone) were within normal range. Results of LH-releasing hormone stimulation tests demonstrated central pubertal responses. Glutamine, dopamine and noradrenaline are most important excitatory neurotransmitters that have a role at the beginning of puberty. The effect of MPH, cumulating dopamine and noradrenaline in the synaptic gap could be associated with the acceleration of puberty with the excitatory effect of dopamine’s gonadotropin-releasing hormone (GnRH) release, excitatory effect of noradrenaline’s GnRH release and the disappearance of GnRH receptor expression suppressor effect on prolactin disinhibitory effect.
Acceleration
;
Adolescent
;
Attention Deficit Disorder with Hyperactivity
;
Body Mass Index
;
Child
;
Dopamine
;
Endocrinology
;
Follicle Stimulating Hormone
;
Glutamine
;
Gonadotropin-Releasing Hormone
;
Humans
;
Methylphenidate
;
Neurotransmitter Agents
;
Norepinephrine
;
Prolactin
;
Puberty
;
Puberty, Precocious
;
Receptors, LHRH
;
Reference Values
10.Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist.
Min Jin LEE ; Bo Seong YUN ; Seok Ju SEONG ; Mi La KIM ; Yong Wook JUNG ; Mi Kyoung KIM ; Hyo Sook BAE ; Da Hee KIM ; Ji Young HWANG
Obstetrics & Gynecology Science 2017;60(1):69-73
OBJECTIVE: The aim of this study was to evaluate the effect of short-term use of selective progesterone receptor modulator (SPRM) or gonadotropin-releasing hormone (GnRH) agonist on uterine fibroid shrinkage among Korean women. METHODS: This retrospective study involved 101 women with symptomatic uterine fibroids who received ulipristal acetate (SPRM, n=51) and leuprolide acetate (GnRH agonist, n=50) for 3 months between November 2013 and February 2015. The fibroid volume was measured both before and after treatment using ultrasonography, computed tomography, and magnetic resonance imaging. The outcomes were compared between the SPRM and GnRH agonist groups. RESULTS: The median rate of fibroid volume reduction after SPRM treatment was 12.4% (IQR −14.5% to 40.5%) which was significantly lower than the reduction rate observed after GnRH agonist treatment (median 34.9%, IQR 14.7% to 48.6%, P=0.004). 19 of 51 (37.3%) patients with SPRM treatment did not show any response of volume shrinkage, while 7 of 50 (14.0%) women with GnRH agonist showed no response (P=0.007). CONCLUSION: Short-term SPRM treatment yields lower volume reduction than GnRH agonist treatment in Korean women with symptomatic fibroids. Further large-scale randomized trials are needed to confirm our findings.
Female
;
Gonadotropin-Releasing Hormone*
;
Humans
;
Leiomyoma*
;
Leuprolide
;
Magnetic Resonance Imaging
;
Progesterone*
;
Receptors, Progesterone*
;
Retrospective Studies
;
Ultrasonography